Angiogenesis agents
Marcinkiewicz, C.
Current Pharmaceutical Design 15(4): 343-344
2009
ISSN/ISBN: 1381-6128 PMID: 19199961 Document Number: 633872
Document emailed within 1 workday
Related Documents
Weber, W.A.; Haubner, R.; Vabuliene, E.; Kuhnast, B.; Wester, H.J.; Schwaiger, M. 2001: Tumor angiogenesis targeting using imaging agents Quarterly Journal of Nuclear Medicine: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology 45(2): 179-182McKinnon, C. 1999: Prostate cancer, biological therapy, signal transduction inhibitors and anti-angiogenesis agents Idrugs: the Investigational Drugs Journal 2(7): 624-628
Horsmans, Y.; Larrey, D.; Pessayre, D.; Benhamou, J.P. 1990: Hepatotoxicity of antimicrobial agents. II: Urinary antiseptics, antitubercular agents, antiparasitic agents, antifungal agents, antiviral agents Gastroenterologie Clinique et Biologique 14(12): 919-924
Ono, M.; Kuwano, M. 2001: Tumor angiogenesis and tumor angiogenesis inhibitors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(5): 584-590
Lumholtz, I.B. 1981: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 16. (3). Anti-arrhythmia agents with action on ventricular arrhythmias Sygeplejersken 81(2): 15
Ohata, K.; Kohno, S. 1987: Progress of therapeutic agents for asthma--3) Trends in the development of leukotriene inhibitory agents Nihon Rinsho. Japanese Journal of Clinical Medicine 45(8): 1843-1852
Nightengale, B.S.; Crumly, J.M.; Liao, J.; Lawrence, B.J.; Jacobs, E.W. 1998: Economic outcomes of antipsychotic agents in a Medicaid population: traditional agents vs. risperidone Psychopharmacology Bulletin 34(3): 373-382
Jacobs, M.R. 2005: Antimicrobial Agents and Resistance--Fifth International Symposium. Antifungal agents and novel vaccines IDrugs: the investigational drugs journal 8(7): 547-550
Personne, M.; Sjöberg, G. 2008: Toxicity in overdoses with new antidepressive agents. a survey of records shows different severity symptoms for different agents Lakartidningen 105(3): 125-127
Lumholtz, I.B. 1977: Drug information: agents in the treatment of neoplastic diseases. Therapeutic main group: cytostatic agents. 1 Sygeplejersken 77(16): 13
Ulmer, W.T.; Dorsch, J.; Iravani, J.; Schüler, K.G.; Stempel, G.; Vastag, E. 1973: Anticholinergic agents as bronchodilator agents. Significance of acetylcholine as a bronchoconstrictor transmitter agent in airway obstruction Arzneimittel-Forschung 23(3): 468-476
Fernández-Viadero, C.; Verduga, R.; Soto, J.; Alsar, M.J. 1993: The use of topical non-steroidal anti-inflammatory agents in elderly patients taking oral anticoagulation agents Medicina Clinica 100(5): 196-197
Gosselin, O.; Di Scala, G.; Ribeyre, J.M.; Kahn, J.P. 1996: New antipsychotic agents: new paths of research on the notion of atypical agents L'Encephale 22(Special Issue 6): 3-6
Lequesne, M.; Cadet, C. 1998: Do 'chondroprotective agents' agents exist in osteoarthritis? Required proof Therapie 53(1): 7-16
Qin, Z.H.; Xie, Y.Y. 1993: Studies on uranium mobilization agents VI: synthesis of 2,3-dihydroxy-4-carbomethoxybenzyl aminocarboxylic acid amides chelating agents Yao Xue Xue Bao 28(8): 619-622
Lown, J.W. 1988: Lexitropsins: rational design of DNA sequence reading agents as novel anti-cancer agents and potential cellular probes Anti-Cancer Drug Design 3(1): 25-40
Lumholtz, I.B. 1980: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 14. Digitalis glycosides Sygeplejersken 80(50): 13
Jumbe, N.L.'N.é 2002: Erythropoietic agents as neurotherapeutic agents: what barriers exist? Oncology 16(9 Suppl 10: 91-107
Veje, V.O. 1981: Drug information: antiparkinson agents. I. Anticholinergic agents Sygeplejersken 81(34): 11
Suda, T.; Takakura, N.; Oike, Y. 2000: Hematopoiesis and angiogenesis International Journal of Hematology 71(2): 99-107